Community stigma endorsement and voluntary counseling and testing behavior and attitudes among female heads of household in Zambézia Province, Mozambique by unknown
Mukolo et al. BMC Public Health 2013, 13:1155
http://www.biomedcentral.com/1471-2458/13/1155RESEARCH ARTICLE Open AccessCommunity stigma endorsement and voluntary
counseling and testing behavior and attitudes
among female heads of household in Zambézia
Province, Mozambique
Abraham Mukolo1*, Meridith Blevins1, Bart Victor4, Heather N Paulin5, Lara ME Vaz1,2, Mohsin Sidat3
and Alfredo E Vergara1Abstract
Background: Some aspects of HIV-related stigma have been shown to be a barrier to HIV services uptake and
adherence to antiretroviral treatment (ART). Distinguishing which domains of stigma impact HIV services uptake
can enhance the efficacy and efficiency of stigma-reduction interventions.
Methods: The relationships between use of voluntary counseling and testing (VCT) services and two domains of
community stigma identified through factor analysis, negative labeling/devaluation and social exclusion, were
investigated among 3749 female heads of household. Data were from a general household survey conducted in
rural Mozambique. Multivariable logistic regression outcomes were: lifetime VCT use, past-6-months VCT use and
VCT endorsement.
Results: Thirteen percent (13%) of the participants reported lifetime VCT use, 10% reported past-6-months VCT
use and 63% endorsed VCT. A 25-point decrease (from 50 to 25) in the score for negative labeling and devaluation
stigma was associated with increased lifetime VCT use (adjusted OR: 1.6, 95% CI: 1.1-2.3) and past-6-months VCT
use (adjusted OR: 1.6, 95% CI: 1.1-2.4). A decrease from 50 to 25-points in the score for social exclusion stigma was
associated with 1.5 and 1.3-fold increase in odds for past-6-months VCT use and endorsing VCT use, respectively
(p < 0.001 for both). Compared with never-testers, considerably high endorsement of VCT use was observed among
testers who did not receive HIV test results (adjusted OR: 2.7, 95% CI: 1.6-4.6) and much higher among testers who
received results (adjusted OR: 7.3, 95% CI: 4.9-11.0). Distance from health facilities was associated with lower VCT
use, but not lower endorsement of VCT.
Conclusions: VCT use and endorsement might differ by domains of stigma held by individuals in the community.
Greater uptake and favorable disposition towards use of VCT services in rural settings might be achieved by
addressing stigma via domain-specific interventions and by improving the proximity of services and the
dissemination of HIV test results.
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Community attitudes towards people living with HIV/
AIDS impact the utilization of HIV care and treatment
services [1,2]. An increase in knowledge about HIV
transmission, prevention and treatment that is created
through the increased availability of HIV care and treat-
ment services, has been shown to diminish negative
community attitudes [3]. This is particularly relevant if
misinformation and ‘erroneous’ beliefs about HIV/AIDS
are reduced in the process of service uptake [4]. How-
ever, HIV stigma seems to persist as a barrier to HIV
services uptake and patients’ adherence to antiretroviral
treatment (ART) despite the scale-up of HIV care and
treatment services [1,5-7].
Research has shown stigma to be a multidimensional
construct [8-10] and to be manifested in a variety of
contexts [11]. The literature on HIV-related stigma has
identified some key domains of stigma, such as negative
labeling, devaluation, status loss and social exclusion,
that are observable at the community (or public), institu-
tional and intrapersonal levels [8,12,13]. More precise
specification of the effects that these individual domains
of stigma have on the use and endorsement of voluntary
counseling and testing (VCT) services is needed, in
order to develop effective (targeted) stigma reduction
strategies [5,6]. Furthermore, while the advantages of
investigating stigma in varying contexts of HIV know-
ledge and public health response to the HIV epidemic
have been suggested [14], domain-specific literature is
sparse. Negative social norms that are created and main-
tained at a community level, such as community stigma,
are likely to influence the use of HIV services by individ-
uals [3]. For example, poor adherence to HIV treatment
tends to be high among patients who think HIV is highly
stigmatized in their community [1,15]. Thus, one’s en-
dorsement of community stigma would influence her
behavior and attitudes regarding the use of VCT.
Using data from female heads of household in a rural
setting in Mozambique, we examined the relationship
between endorsement of two domains of community
stigma identified through factor analysis — negative
labeling/devaluation (NLD) and social exclusion (SoE) —
and these women’s participation in and attitudes toward
VCT services. As in many high HIV/AIDS prevalence
areas, women between the ages of 15 and 45 years are
targeted under interventions to scale up the prevention
of mother-to-child transmission (PMTCT) of HIV in
Mozambique [16-19]. The questions we addressed are:
Does endorsement of community stigma have a signifi-
cant association with VCT use and endorsement? If an
association is present, is it significant after adjusting for
increased knowledge about HIV/AIDS and service
provision barriers? Do these associations significantly
differ by domains of community stigma?Methods
Survey background and design
A population-based survey called the Ogumaniha-SCIP
survey was conducted in late 2010 among 3749 female
heads of household in 259 randomly selected enumer-
ation areas across 14 districts of Zambézia Province,
Mozambique [20]. In the Echuabo language, Ogumaniha
means “united/integrated for a common purpose”; SCIP
stands for “Strengthening Communities through Inte-
grated Programming,” which is a project funded by the
United States Agency for International Development
(USAID) and implemented by a consortium of partners
led by World Vision, Inc. Data were collected in two
phases: first, we collected a Zambézia-wide sample to
provide province-wide estimates, then we focused on
three districts [20] to generate more precise baseline
estimates. Interviews covered various topics, including
socio-demographics, access to healthcare, HIV know-
ledge and attitudes towards people living with HIV/
AIDS (PLWHA). Details about sampling, data collection
and management protocols have been published else-
where [20]. Approximately 99.1% of all households
approached consented to participate in the study, which
was approved by the Mozambican national bioethics com-
mittee and the Institutional Review Board at Vanderbilt
University.
VCT outcomes
We examined three aspects of voluntary counseling
and testing (VCT) use, including overall or “lifetime”
VCT use, VCT use during the 6 months before the
interview, and general endorsement of VCT use. Overall
VCT use was assessed using data from responses to the
following questions: (1) ‘Have you received voluntary
counseling and testing (VCT) in the past 6 months?’ and
(2) ‘Have you ever received voluntary counseling and test-
ing (VCT) at any time during your life prior to the last
6 months?’ A “lifetime VCT use” score was generated
by combining responses to both questions, such that
responding affirmatively to either question indicated
lifetime VCT use. A “past-6-months VCT use” score
was also analyzed separately. Attitudes about VCT
use were assessed by generating a “VCT endor-
sement” score based on responses to the question:
‘Do you think it is worthwhile to receive voluntary
counseling and testing and learn your HIV status?’
The skip pattern in the survey was structured such
that this question was posed only to participants who
responded affirmatively to the question: ‘Have you
ever heard of VCT services?’ All three aspects of VCT
use, “lifetime VCT use”, “past-6-months VCT use”
and “VCT endorsement” were analyzed as binary
variables (1 = used or worthwhile; 0 = not used or not
worthwhile).
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Stigma items were adapted from a questionnaire used by
Pulerwitz et al. [2,21], which lists 15 items reflecting
stigmatizing attitudes, beliefs and behaviors that a par-
ticipant endorses on a 4 point Likert scale from “strongly
disagree” to “strongly agree.” The statements reflect
labels and stereotypes that devalue and reduce a person
with HIV to a tainted and socially undesirable status
[8,10,22,23], as well as specific exclusionary actions
towards PLWHA (see Additional file 1 for details). The
original stigma measure [2] was modified to tailor ques-
tions to our sample of female heads of household. Two
dimensions of stigma, negative labeling/devaluation
(NLD) and social exclusion (SoE), were generated through
factor analysis of the 15 stigma items, specifically principal
components analysis, with orthogonal varimax rotation,
by using STATA 11.2 (http://www.stata.com). Cronbach
alphas were 0.74 for NLD and 0.73 for SoE, which
explained 94.7% of the variance. These Cronbach alphas
were comparable to those reported by Pulerwitz et al.
(α = 0.76 for the combined 15-item scale) [2,21], indi-
cating acceptable reliability in our context. Items in each
dimension of stigma were scored such that higher scores
denoted greater stigma. Scales for each dimension were
calculated by taking the mean value of non-missing items
and then normalized to a 0–100 range.
Other correlates
Several other expected correlates of HIV services uptake
were considered, including participant’s age, years of
education, marital status, distance from the clinic/health
facility, living in an isolated district versus living in a
district close to the provincial capital, religious affili-
ation, knowledge of HIV transmission, perceived risk of
HIV infection, experience/familiarity with HIV infection,
belief in ART efficacy (as proxy for being favorably
disposed to HIV care and treatment services), healthcare
services access/contact and health-related quality of life
(as proxy for self-evaluated state of health). State of
health was considered because the literature suggests
that perceived ill-health likely motivates HIV testing
[24]. Past testing behavior has been found to predict
current and future testing behavior in a similar popu-
lation [25]. Thus, for attitudes towards VCT use, the
impact of receiving versus not receiving HIV test results
at the last VCT visit was also considered, as it assesses
the quality of past experience with VCT. We assumed
that not receiving test results after completing VCT
would be negatively associated with attitudes towards
VCT, whereas receiving results would have no associ-
ation, because it is an expected outcome of VCT.
Knowledge about HIV transmission was measured by
the number of correct responses to questions regarding
HIV transmission routes and ways to prevent them. Weassessed five domains of knowledge, including know-
ledge typically covered in public health education cam-
paigns and targeted health education programs
conducted in health centers and community settings.
The focus was on knowledge about adult-to-adult and
mother-to-child transmission routes and transmission
via casual contact (see Additional file 1 for details). A
count of correct responses was taken for each of the five
questions and categorized as follows: 0 = No correct
responses, 1 = One correct response and 2 = Two or
more correct responses. A summative score (range: 0–
10 points) was generated with higher scores indicating
higher (and better) knowledge.
Perceived risk of HIV infection, which is known to
influence HIV testing behavior, was assessed by asking:
‘What are the chances you might become infected with
HIV?’ Responses options were coded as follows: 1 =No
chance, 2 = Small chance, 3 =Good chance and 4 =Already
infected. Non-response or responses of “Don’t know” were
also recorded. Perceived risk was treated as a categorical
variable with non-responses and “Don’t know” responses
collapsed into a single category.
Experience/familiarity with HIV infection was
assessed through participants’ direct experience with
HIV infection, which has been shown to moderate
attitudes towards PLWHA, consistent with findings
about other socially stigmatized conditions like mental
illness [11]. Participants were considered to have dir-
ect experience/familiarity with HIV infection if they
gave a positive response to at least one of the follow-
ing questions: ‘Do you have relatives with HIV?’, ‘Do
you have friends with HIV?’ or ‘Do you have HIV?’
For ethical and other considerations, since the last
question was posed to women who reported using
PMTCT services, responses were validated by comparing
the total number of positive responses with the number
reporting that they were already infected when asked:
‘What are the chances that you might become infected
with HIV?’.
Belief about the efficacy of ART was assessed by asking:
‘Do you think antiretroviral treatment helps people with
HIV to be healthier?’ and ‘Do you think alternative
treatments available in the community or from traditional
healers can help people with HIV?’ Each item was treated
as a distinct binary variable in the analyses.
Healthcare services access/contact was assessed by
asking about three different healthcare systems that
participants could utilize: government health centers or
hospitals, private pharmacies and traditional healers.
Each item was treated as a distinct binary variable in the
analyses. The frequency of visits to each system was not
estimated due to data reliability issues.
Quality of life (QoL) was assessed using an adapted
version of the WHOQOL-BREF, a 31 item measure of
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being, psychological well-being, independence, social
relationships, environment and spirituality. The scale
has been shown to have good psychometric properties in
a similar population from Botswana (physical well-being
α = 0.74, psychological well-being α = 0.53, independence
α = 0.72, social relationships α = 0.71, environment α = 0.73,
spirituality α = 0.47) [26]. Ten of the 31 items deemed
relevant to the cultural context of Mozambique were
selected (see Additional file 1 for the list). Factor analysis
revealed that these 10 items capture two distinct dimen-
sions of QoL that are consistent with the literature [27]:
QoL-chronic (or long-term well-being) and QoL-acute
(short-term well-being). QoL-chronic (α = 0.83) consists
of the two global health ratings, plus daily living,
capacity to work, access to health treatment and mo-
bility. QoL-acute (α = 0.68) includes physical pain, de-
pendence on medication/treatment, energy/vitality and
negative feelings. Only the QoL-chronic scale was used in
subsequent analyses, since lifetime VCT use was being
examined.Figure 1 Marginal log-odds of HIV testing for negative labeling and d
log-odds (adjustment values are medians or categories with largest propor
months (Panels C and D) for negative labeling and devaluation stigma (PStatistical methods
We modeled the probability of our VCT outcomes, life-
time VCT use, past-6-months VCT use and VCT endor-
sement, by using multivariable logistic regression. The
primary predictors were the two dimensions of commu-
nity stigma, NLD and SoE. We used a regression spline
model [28,29] which predicts each VCT outcome from
several independent variables because some predictor
variables, like NLD and SoE, had curvilinear distribu-
tions. For example, the curvilinear relationship between
stigma scales and the VCT use scores can be seen in
Figure 1. When there was evidence of nonlinearity,
continuous variables were modeled using restricted
cubic splines [28]. Thus, the two stigma variables (NLD
and SoE) enter each model as nonlinear, continuous
variables. The restricted cubic splines method ensures
that the distributions of the stigma variables entered in
the model fit the actual stigma data. Rather than forcing
stigma variables to be linear, their functions/distributions
are more appropriately represented by knots whose posi-
tions are “determined automatically according to equallyevaluation stigma and social exclusion. Covariate-adjusted
tions) of ever testing (Panels A and B) or testing during the past six
anels A and C) and social exclusion stigma (Panels B and D).
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four knots were placed at the 5th, 35th, 65th and 95th
percentiles of the distribution [28]. Multiple imputation
was used to account for missing values for baseline pre-
dictors and to prevent case-wise deletion of missing
data. We used the functions ‘aregImpute’ and ‘fit.mult.
impute’ in the Hmisc package of R, which uses predict-
ive mean matching to take random draws from imput-
ation models; 10 imputation data sets were used in the
analysis. Covariates were selected a priori, including
knowledge about HIV/AIDS transmission and treatment,
perceived risk of HIV infection, healthcare service
access/contact and socio-demographic factors typically
associated with VCT use behaviors and attitudes, such
as age, education and marital status [30]. Wald statistics
were used to test the significance of linearity, interaction,
and covariate effects in each of the three outcome
models [31]. When significant, we also included an
interaction effect between both stigma scales. All
hypothesis testing was two-sided with a level of sig-
nificance set at 0.05. We employed R-software 2.13.1
(www.r-project.org) for all data analyses.
Results
Table 1 shows the characteristics of the study popula-
tion. Of the 3749 female heads of household inter-
viewed, 489 (13%) reported lifetime voluntary counseling
and testing (VCT) use and 374 (10%) reported past-6-
months VCT use. Data about the importance of VCT
was available for 1069 participants, i.e., those who
responded affirmatively when asked if they knew about
the existence of VCT services and had no missing data
on the importance of VCT. Of these, 676 (63.2%) agreed
with the statement that it is worthwhile to use VCT and
learn about your HIV status. The median age of partici-
pants (n = 3749) was 29 years (interquartile range (IQR):
23–36 years) and did not differ by level of stigma (for
either stigma scale). Half of the participants had at least
2 years of education and less than 25% had more than
4 years of education; 57% resided in districts regarded as
isolated. Approximately 75% said they were married or
in common-law relationships, and 17% said they were
single. Religious affiliations showed significant diversity:
47% were Catholic, 34% were non-Catholic Christians,
9% were Muslim and about 10% were other religions.
Less that 50% were fluent in Portuguese, the country’s
official language. The average distance from the center
of the enumeration areas to the nearest public health
facility was 6.2 km (IQR: 3.2-10.3 km). About 48% were
unaware of their HIV infection risk, 25% were confident
that they were not at any risk of HIV infection, while
25% thought they were at risk of being infected with
HIV. About 2% disclosed that they were HIV positive.
The original survey was not designed to estimate HIVprevalence, so data on HIV serostatus were unreliable.
Nonetheless, familiarity with HIV infection through
awareness of one’s own or a friend/close relative’s seros-
tatus was low (12%). Self-reported health-seeking behav-
ior varied by type of healthcare sought: 76% reported
lifetime use of government health facilities, 22% reported
use of private pharmacies and 46% reported use of
traditional healers. About one third believed that ART
helps people with HIV to be healthier, and about 9%
thought there were alternative treatments for HIV in the
community, including from traditional healers.
In unadjusted analyses (Table 1), participants who
engaged in and/or positively endorsed VCT use gener-
ally had lower median stigma scores than participants
who did not engage in and/or positively endorse VCT
use. Differences in the medians for negative labeling/de-
valuation (NLD) scores were not statistically significant,
but differences in the medians for social exclusion (SoE)
scores were statistically significant.
Correlates of VCT services uptake
Results for lifetime and past-6-months VCT use are
presented in Table 2. In adjusted analyses, a 25-point
increase (from 50 to 75) in the NLD score was associ-
ated with a 37% drop in odds for lifetime VCT use; that
is, a 25-point decrease (from 75 to 50) in the NLD score
was associated with 1.6-fold increase in lifetime VCT
use (adjusted OR: 1.63, 95% CI: 1.14-2.32). A 50-point
drop (from 100 to 50) in NLD was associated with a 2.7-
fold increase in lifetime VCT use (adjusted OR: 2.68,
95% CI: 1.30-5.50). The relationship between the SoE
score and lifetime VCT use was of marginal statistical
significance (p = 0.097). Other exposures inversely asso-
ciated with lifetime VCT use included age and distance
to the nearest clinic. Positive associations were found for
knowledge of HIV transmission routes, awareness of
HIV infection, access/contact with public health facilities
and private pharmacies, belief in ART efficacy, belief in
the efficacy of alternative treatments for HIV and
perceived risk of HIV infection. The perceived risk of
HIV infection categories small chance, good chance and
already infected each showed statistically significant odds
of lifetime VCT use compared with the reference cat-
egory (non-response/don’t know).
Both the NLD and SoE stigma scores were associ-
ated with low odds of past-6-months VCT use. An
NLD score of 75 versus 50 resulted in 63% higher
odds of past-6-months VCT use (adjusted OR: 1.63,
95% CI: 1.10-2.41). A SoE score of 25 versus 50 (i.e.,
25-point increase) was associated with a 32% decrease
in past-6-months VCT use (adjusted OR: 0.68, 95%
CI: 0.53-0.86). That is, a 25-point decrease in the SoE
score from 50 to 25 was associated with 1.5-fold in-
crease in odds of past-6-months VCT use. A 50-point
Table 1 Characteristics of participants by VCT use indicators














(n = 3260) (n = 489) (n = 3375) (n = 374) (n = 393) (n = 676)
Reside in isolated districtb 41.0 37.5 <0.001 59.2 62.6 0.007 57.1 63.9 0.017
Understand Portuguese 36.6 49.6 <0.001 36.7 53.6 <0.001 42.6 49.0 0.002
Marital status 0.063 0.010 0.951
Married 74.9 69.8 73.7 75.9 73.5 71.3
Divorced/separated 3.8 4.0 4.0 2.% 6. 3.3
Single 17.0 19.1 18.0 13.9 16.7 18.1
Widowed 4.3 7.1 4.4 7.5 3.5 7.3
Religion 0.393 0.898 0.088
Catholic 45.0 41.4 45.4 37.6 42.7 44.7
Protestant 13.7 20.1 13.8 21.6 10.5 16.8
Evangelical/Pentecostal 15.7 20.2 16.1 19.1 14.1 16.4
Other Christianc 3.9 6.2 3.8 7.5 5.2 8.3
Muslim 9.9 4.4 9.7 4.0 14.2 4.8
Non-Christian Eastern 2.9 1.0 2.7 1.2 1.7 1.9
Otherc 8.9 6.8 8.4 9.0 11.6 7.2
HIV infection of self, relative
and/or friend
8.0 25.2 <0.001 8.5 28.1 <0.001 9.8 24.9 <0.001
Accessed health facility 70.6 87.8 <0.001 71.7 87.0 <0.001 82.8 83.4 0.002
Accessed pharmacy 19.6 29.5 <0.001 19.8 31.6 <0.001 32.0 34.3 0.092
Accessed traditional healer 43.4 46.6 0.005 44.6 40.2 0.108 41.7 50.6 0.005
Believes ART helps people with
HIV to be healthier
20.4 64.5 <0.001 22.7 65.1 <0.001 26.1 65.9 <0.001
Believes in alternative treatments
for HIV
5.7 18.1 <0.001 6.3 19.0 <0.001 5.9 17.4 <0.001
Perceived chance of becoming
infected with HIV
<0.001 <0.001 0.036
Don’t know 54.1 40.5 53.7 37.7 60.9 39.4
No chance 25.1 15.8 24.1 18.6 15.3 22.2
Small chance 15.3 26.4 15.4 29.7 14.7 23.1













Age (years) 29 (23–38) 26 (22–35) <0.001 29 (23–38) 25 (22–33) <0.001 28 (23–35) 26 (23–34) 0.004
Education (years) 1 (0–4) 3 (0–5) <0.001 1 (0–4) 4 (0–5) <0.001 2 (0–4) 3 (0–6) <0.001
Distance to clinic (km) 7.2 (4.1 - 10.4) 4.3 (0.6-9.3) <0.001 7.2 (3.9-10.4) 4.1 (0.6 - 9.3) <0.001 6.1 (3–9.4) 4.6 (0.6-9.1) 0.006
Negative labeling and
devaluation
38 (29–50) 33 (26–48) 0.496 38 (29–50) 37 (30–48) 0.859 44 (33–53) 38 (29–48) 0.788
Social exclusion 47 (33–67) 40 (27–56) <0.001 47 (33–60) 40 (26–53) <0.001 47 (32–67) 40 (27–53) <0.001
[a] Continuous variables were analyzed as weighted estimates of medians (interquartile range), with each observation weighted by the inverse of the household
sampling probability. Categorical variables were analyzed as weighted percentages, with each observation being weighted by the inverse of the household
sampling probability. Tests of association with VCT outcomes (binary) were conducted using the rank sum test (continuous) or chi-square test (categorical).
[b] Isolated districts include Inhassunge, Milange, Morrumbala, Mopeia, Gile, Maganja da Costa and Lugela.
[c] ‘Other Christian’ includes LDS Mormon and Jehovah’s Witness. ‘Other’ includes Spiritual, Traditional Religions, and Agnostic or Atheist.
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Table 2 Adjusted odds ratios and overall tests of significance for lifetime VCT use and past-6-months VCT use
Lifetime VCT use Past-6-months VCT use
Variable OR 95% CI P-value OR 95% CI P-value
Negative labeling and devaluation (Ref = 50 pts)a 0.025 0.053
0 pts 1.05 0.62 – 1.78 1.25 0.70 – 2.24
25 pts 0.87 0.72 – 1.05 0.94 0.76 – 1.15
75 pts 1.63 1.14 – 2.32 1.63 1.10 – 2.41
100 pts 2.68 1.30 – 5.50 2.69 1.21 – 5.98
Social exclusion (Ref = 50 pts)a 0.097 0.006
0 pts 0.57 0.34 – 0.95 0.43 0.25 – 0.73
25 pts 0.78 0.62 – 0.98 0.68 0.53 – 0.86
75 pts 0.97 0.79 – 1.20 0.88 0.69 – 1.11
100 pts 0.85 0.50 – 1.45 0.63 0.35 – 1.13
Age (per 10 years) 0.83 0.73 – 0.94 0.002 0.84 0.74 – 0.96 0.01
Education (per 5 years) 1.21 0.94 – 1.55 0.14 1.15 0.88 – 1.50 0.3
Distance to clinic (per 5 km) 0.82 0.74 – 0.92 0.001 0.87 0.77 – 0.98 0.02
Reside in isolated district 1.02 0.79 – 1.33 0.9 1.02 0.76 – 1.36 0.9
Understand Portuguese 1.24 0.95 – 1.61 0.11 1.47 1.10 – 1.96 0.009
Marital status (Ref = married/common law) 0.3 0.065
Divorced/separated 0.63 0.32 – 1.24 0.28 0.11 – 0.74
Single 1.18 0.90 – 1.55 1.07 0.80 – 1.45
Widowed 1.14 0.67 – 1.94 0.87 0.47 – 1.64
Religion (Ref = Catholic) 0.4 0.14
Evangelical and Pentecostal 1.16 0.84 – 1.61 1.02 0.70 – 1.49
Muslim 0.90 0.59 –1.35 0.86 0.54 –1.37
Non-Christian Eastern 1.61 0.83 – 3.10 1.69 0.85 – 3.34
Other Christian 0.80 0.44 – 1.45 0.82 0.43 – 1.54
Other 1.39 0.90 – 2.15 1.67 1.08 – 2.60
Protestant 1.19 0.80 – 1.76 1.28 0.85 – 1.95
Quality of life score (per 20 pts) 1.11 0.95 – 1.30 0.18 1.07 0.91 – 1.26 0.4
HIV knowledge score (8 versus 0 pts) 2.11 1.27 – 3.50 0.018 2.13 1.22 – 3.73 0.009
HIV infection of self, relative and/or friend 1.99 1.43 – 2.76 <0.001 1. 89 1. 34–2.67 <0.001
Accessed health facility 1.67 1.27 – 2.19 <0.001 1.38 1.03 – 1.85 0.03
Accessed pharmacy 1.39 1.07 – 1.82 0.014 1.46 1.09 – 1.94 0.01
Accessed traditional healer 1.05 0.84 – 1.32 0.7 0.96 0.75 – 1.23 0.7
Believes that ART helps people with HIV to be healthier 3.46 2.65 – 4.52 <0.001 2.98 2.21 – 4.00 <0.001
Believes in alternative treatments for HIV 2.08 1.48 – 2.92 <0.001 2.18 1.53 – 3.11 0.0002
Perceived chance of becoming infected with HIV
(Ref = non-response/don’t know)
<0.001 <0.001
Already infected 5.15 2.42 – 11.0 4.00 1.90 – 8.43
Good chance 2.27 1.54 – 3.35 1.77 1.14 – 2.76
Small chance 1.71 1.28 – 2.29 1.57 1.14 – 2.15
No chance 0.97 0.71 – 1.31 1.12 0.81 – 1.54
NLD Negative labeling and devaluation; SoE Social exclusion; OR odds ratio, CI confidence interval. If the 95% CI excluded 1, then there was a significant pairwise
association between that category and the outcome. There was little evidence of an interaction between NLD and SoE with lifetime VCT use or past-6-months
use (p > 0.6).
[a] NLD, SoE and HIV knowledge scores were modeled using restricted cubic splines with 4 knots.
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Correlates of the view that “It is worthwhile to receive
VCT and learn your HIV status”
Table 3 presents results for perceived importance of
VCT and learning about one’s HIV status. A high NLD
stigma score was associated with low odds of endorsing
the statement, “It is worthwhile to receive VCT and learn
your HIV status” (adjusted OR: 0.94, 95% CI: 0.77-1.15,
p = 0.04). The SoE stigma score showed an even stronger
inverse association (adjusted OR: 0.75, p < 0.001). That is,
a 25-point decrease in the SoE score was associated a 1.3-
fold increase in odds of endorsing VCT. Similarly, scores
for QoL-chronic, HIV knowledge, quality of last VCT
service accessed, contact with traditional healers and belief
in ART efficacy were each associated with higher odds of
endorsing VCT. Living in an isolated district compared
with not living in an isolated district was associated with
lower odds of endorsing VCT (p = 0.047). When compar-
ing participants who knew about the existence of VCT
services with those who did not, awareness of VCT was
related to lower endorsement of SoE, but not to endorse-
ment of NLD.
Discussion
In this study of the relationships between stigma (negative
labeling and devaluation (NLD) and social exclusion (SoE)
stigmas) and the use and endorsement of voluntary
counseling and testing (VCT) services, the importance of
VCT was acknowledged by more than half of the study
participants (63%), but actual use was low (only 13%
reported lifetime VCT use). Similarly low levels of VCT
use have been reported in other studies from Sub-Saharan
Africa [32,33]. Thus, there is a need to investigate barriers
to VCT use among individuals who have favorable opin-
ions about the importance of testing for HIV infection in
Zambézia Province and other parts of Sub-Saharan Africa.
In general, stigma seems to have a negative association
with VCT use and the perceived importance of VCT
use. This association is independent of associations with
knowledge about HIV transmission and treatment,
perceived risk of HIV infection, familiarity with HIV
infection, healthcare services access/contact, health-
related quality of life, belief in ART efficacy and structural
barriers like distance to a clinic and delays in disseminat-
ing HIV test results to VCT users. Thus, unraveling the
specific aspects of stigma that impede VCT use and the
complex intersections among them is needed. These data
suggest that the relationship between endorsement of
community stigma and VCT uptake depends on the
domains of the stigma under consideration. In particular,
endorsement of SoE was associated with low odds of
past-6-months VCT use and low perceived importance ofVCT, but was not associated with lifetime VCT use.
Endorsement of NLD of people living with HIV/AIDS
(PLWHA) was associated with significantly lower odds of
lifetime VCT use and marginally lower odds of past-6-
months VCT use, but was not associated with perceived
importance of VCT. Since awareness of VCT was related
to lower SoE, but not NLD, it is plausible that acquiring
information about VCT (or exposure to such information)
mitigates the tendency to socially exclude PLWHA,
whereas negative stereotypes of PLWHA might be more
entrenched in the community and less amenable to
change with increased knowledge of VCT. Due to non-
linearity, the impact of changes in stigma scores that we
report upon (i.e. 25 and 50 point changes) might not
accurately reflect the impact of smaller changes on the
stigma scales. By having Figure 1, the reader should be
able to judge the relationship for the whole range of values
that the stigma scales may take on.
Nonetheless, evidence regarding the domain-specificity
of stigma and its effect on VCT use and endorsement is
somewhat weak. In fact, the potential effects of NLD
stigma on VCT use and endorsement were only evident
in adjusted analysis, and the effects of SoE, though
relatively robust, were confounded by other factors.
These two domains of community stigma seem to have
smaller effect sizes than the effects of the other cova-
riates considered. Therefore, it is important to con-
sider the effects of some of the covariates examined
in this study.
Most of our findings about correlates of VCT use and
endorsement are consistent with the literature on VCT
from various settings [2,32,33]. For example, VCT use is
less likely among older people than among younger
people, with an increase in distance between the nearest
health facility and one’s place of residence and/or with a
decrease in perceived risk of HIV infection. Our data
suggest that the quality of past testing is also important.
In particular, receiving versus not receiving HIV test
results was associated with perceived importance of
VCT services. Compared with participants who had
never been tested, the adjusted OR for endorsing VCT
use was 2.71 among those who had tested but had not
received their HIV test results in the past and was 7.33
among those who had both tested and received their
results. Thus, organizational factors such as efficient and
reliable communication of test results should not be
overlooked in studies investigating patient- and commu-
nity-level barriers to VCT use such as community stigma.
In addition, greater knowledge of HIV transmission routes
predicted lifetime VCT use, past-6-months VCT use and
positive attitudes towards VCT. Increased distance be-
tween one’s residence and the nearest public health facility
was associated with less VCT use (lifetime and past-6-
months), but not with attitudes towards VCT. This is
Table 3 Adjusted odds ratios and overall tests of significance for endorsing VCT use
It is worthwhile to receive VCT and learn your HIV status
Variablea OR 95% CI P-value
Negative labeling and devaluation (Ref = 50 pts)a 0.04
0 pts 1.14 0.68 – 1.91
25 pts 1.07 0.83 – 1.38
75 pts 0.94 0.72 – 1.21
100 pts 0.88 0.52 – 1.47
Social exclusion (Ref = 50 pts)a <0.001
0 pts 1.96 1.23 – 3.10
25 pts 1.40 1.11 – 1.76
75 pts 0.71 0.56 – 0.90
100 pts 0.51 0.32 – 0.81
Age (per 10 years) 0.91 0.76 – 1.08 0.3
Education (per 5 years) 0.91 0.62 – 1.34 0.6
Distance to clinic (per 5 km) 0.96 0.81 – 1.14 0.6
Reside in isolated district 0.68 0.47 – 0.99 0.047
Understand Portuguese 0.95 0.65 – 1.40 0.8
Marital status (Ref = married/common law) 0.8
Divorced/separated 1.00 0.41 – 2.43
Single 0.83 0.55 – 1.25
Widowed 1.00 0.48 – 2.07
Religion (Ref = Catholic) 0.5
Evangelical and Pentecostal 0.73 0.44 – 1.19
Muslim 1.15 0.67 – 1.97
Non-Christian Eastern 0.64 0.23 – 1.76
Other Christian 0.54 0.24 – 1.22
Other 0.84 0.47 – 1.48
Protestant 1.15 0.64 – 2.06
Quality of life score (75 versus 50 pts) 3.04 1.95 – 4.76 <0.001
HIV knowledge score (5 versus 1 pt) 1.68 1.06 – 2.68 0.047
HIV infection of self, relative and/or friend 1.02 0.62 –1.69 0.9
VCT experience (Ref = Never tested) <0.001
Ever tested & no test results received 2.79 1.64 – 4.73
Ever tested & results received 7.61 5.08–11.4
Accessed health facility 1.27 0.86 – 1.87 0.2
Accessed pharmacy 0.87 0.59 – 1.29 0.5
Accessed traditional healer 1.63 1.17 – 2.28 0.004
Believes that ART helps people with HIV to be healthier 6.47 4.36 – 9.59 <0.001
Believes in alternative treatments for HIV 1.04 0.59 – 1.83 0.2
Perceived chance of becoming infected with HIV (Ref = non-response/don’t know) 0.9
Already infected 1.41 0.41 – 4.79
Good chance 1.20 0.66 – 2.17
Small chance 1.07 0.68 – 1.68
No chance 1.64 1.08 – 2.49
95% CI excluded 1, then there was a significant pairwise association between that category and the outcome.
[a] An interaction term between NLD and SoE was included (p = 0.014); estimates were adjusted to median values (NLD = 41 and SoE = 47). NLD and SoE are
modeled as linear (no evidence of nonlinearity).
Mukolo et al. BMC Public Health 2013, 13:1155 Page 9 of 11
http://www.biomedcentral.com/1471-2458/13/1155
Mukolo et al. BMC Public Health 2013, 13:1155 Page 10 of 11
http://www.biomedcentral.com/1471-2458/13/1155important because, based on age and gender, our partici-
pants are likely to have higher than average contact with
the public health system or at least have high incentives to
seek public healthcare, yet distance, in addition to stigma,
might impede their efforts to seek healthcare services such
as VCT.
A key limitation of this study is its cross-sectional
design, which precludes examination of causality or
temporal effects. While we were able to distinguish two
distinct and internally consistent stigma constructs, our
measure might have missed other important domains of
stigma. The stigma measure could be further refined
and validated in subsequent studies by using confirma-
tory factor analysis techniques. In addition, small effect
sizes for stigma could be due to measurement error. The
need for better and more reliable measures of stigma is
widely acknowledged in the field [8,13,34]. Future re-
search should explore these issues.
Conclusion
Stigma reduction in general, in addition to efforts to
address other known barriers, could have a positive
impact on VCT services uptake. VCT use and endorse-
ment might differ by domains of community stigma.
However, this needs to be further investigated, as does
the potential for domain-specific stigma reduction inter-
ventions. In tandem with stigma reduction efforts, mak-
ing VCT services more accessible by moving them closer
to communities and improving the quality of VCT ser-
vices, such as by ensuring that testers get their results,
could also promote greater uptake and favorable dis-
position towards VCT services among female heads of
household in Zambézia Province, Mozambique.
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